You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
辰欣藥業(603367.SH):上半年淨利降28.96%至1.8億元
格隆匯 08-10 15:38

格隆匯 8 月 10日丨辰欣藥業(603367.SH)披露2020年半年度報告,實現營業收入16.58億元,同比下降15.24%;歸屬於上市公司股東的淨利潤1.8億元,同比下降28.96%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.63億元,同比下降30.65%;基本每股收益0.40元。

受醫改政策影響,公司業務增速放慢但結構優化,當前目標朝着提升藥品質量、優化用藥結構、努力創新升級的方向發展。公司董事會始終堅持以市場為導向,深入客户,服務客户,為客户提供最好的服務與產品,在既定的戰略指引下,繼續調整產業佈局,應對新冠疊加醫改的不利影響。報告期內由於疫情期間醫院端診療服務受到限制,醫院減少病號,致使公司生產的輸液、製劑生產銷售受到一定程度的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account